Xenon Pharmaceuticals Reconciled Depreciation (Quarterly) Analysis

Xenon Pharmaceuticals, Inc. (XENE)

44.62 -0.18 (-0.39%) USD | NASDAQ | Feb 25, 16:00

45.56 +0.94 (+2.12%) After-Hours: 20:00

View Reconciled Depreciation (Quarterly) for XENE.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Reconciled Depreciation (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Reconciled Depreciation (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Reconciled Depreciation (Quarterly) Benchmarks

Start Trial

Oncolytics Biotech, Inc.	Upgrade
Aurinia Pharmaceuticals, Inc.	Upgrade
Edesa Biotech, Inc.	Upgrade
Lexaria Bioscience Corp.	Upgrade
ProMIS Neurosciences, Inc.	--